BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 10358136)

  • 1. Cutting edge: cells that carry A null allele for toll-like receptor 2 are capable of responding to endotoxin.
    Heine H; Kirschning CJ; Lien E; Monks BG; Rothe M; Golenbock DT
    J Immunol; 1999 Jun; 162(12):6971-5. PubMed ID: 10358136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors.
    Means TK; Lien E; Yoshimura A; Wang S; Golenbock DT; Fenton MJ
    J Immunol; 1999 Dec; 163(12):6748-55. PubMed ID: 10586073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of cytokine production in human T cells and monocytes by highly purified lipoteichoic acid: involvement of Toll-like receptors and CD14.
    Ellingsen E; Morath S; Flo T; Schromm A; Hartung T; Thiemermann C; Espevik T; Golenbock D; Foster D; Solberg R; Aasen A; Wang J
    Med Sci Monit; 2002 May; 8(5):BR149-56. PubMed ID: 12011760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural requirements of muramylpeptides for induction of Toll-like receptor 2-mediated NF-kappaB activation in CHO cells.
    Yoshimura A; Takada H; Kaneko T; Kato I; Golenbock D; Hara Y
    J Endotoxin Res; 2000; 6(5):407-10. PubMed ID: 11521064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis.
    Means TK; Wang S; Lien E; Yoshimura A; Golenbock DT; Fenton MJ
    J Immunol; 1999 Oct; 163(7):3920-7. PubMed ID: 10490993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans.
    Arbour NC; Lorenz E; Schutte BC; Zabner J; Kline JN; Jones M; Frees K; Watt JL; Schwartz DA
    Nat Genet; 2000 Jun; 25(2):187-91. PubMed ID: 10835634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4.
    Yamamoto M; Sato S; Hemmi H; Sanjo H; Uematsu S; Kaisho T; Hoshino K; Takeuchi O; Kobayashi M; Fujita T; Takeda K; Akira S
    Nature; 2002 Nov; 420(6913):324-9. PubMed ID: 12447441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of functional LPS receptor proteins CD14 and toll-like receptor 4 in human corneal cells.
    Song PI; Abraham TA; Park Y; Zivony AS; Harten B; Edelhauser HF; Ward SL; Armstrong CA; Ansel JC
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2867-77. PubMed ID: 11687531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptor 2 mediates inflammatory cytokine induction but not sensitization for liver injury by Propioni- bacterium acnes.
    Romics L; Dolganiuc A; Velayudham A; Kodys K; Mandrekar P; Golenbock D; Kurt-Jones E; Szabo G
    J Leukoc Biol; 2005 Dec; 78(6):1255-64. PubMed ID: 16204620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2.
    Hirschfeld M; Kirschning CJ; Schwandner R; Wesche H; Weis JH; Wooten RM; Weis JJ
    J Immunol; 1999 Sep; 163(5):2382-6. PubMed ID: 10452971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical roles of Toll-like receptors in host defense.
    Kaisho T; Akira S
    Crit Rev Immunol; 2000; 20(5):393-405. PubMed ID: 11145217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of toll-like receptor 2 gene expression in macrophage response to peptidoglycan and high concentration of lipopolysaccharide is involved in NF-kappa b activation.
    Liu Y; Wang Y; Yamakuchi M; Isowaki S; Nagata E; Kanmura Y; Kitajima I; Maruyama I
    Infect Immun; 2001 May; 69(5):2788-96. PubMed ID: 11292690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective priming to Toll-like receptor 4 (TLR4), not TLR2, ligands by P. acnes involves up-regulation of MD-2 in mice.
    Romics L; Dolganiuc A; Kodys K; Drechsler Y; Oak S; Velayudham A; Mandrekar P; Szabo G
    Hepatology; 2004 Sep; 40(3):555-64. PubMed ID: 15349893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains.
    Xu Y; Tao X; Shen B; Horng T; Medzhitov R; Manley JL; Tong L
    Nature; 2000 Nov; 408(6808):111-5. PubMed ID: 11081518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease.
    Netea MG; Kullberg BJ; de Jong DJ; Franke B; Sprong T; Naber TH; Drenth JP; Van der Meer JW
    Eur J Immunol; 2004 Jul; 34(7):2052-9. PubMed ID: 15214053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of tolerance to lipopolysaccharide and mycobacterial components in Chinese hamster ovary/CD14 cells is not affected by overexpression of Toll-like receptors 2 or 4.
    Medvedev AE; Henneke P; Schromm A; Lien E; Ingalls R; Fenton MJ; Golenbock DT; Vogel SN
    J Immunol; 2001 Aug; 167(4):2257-67. PubMed ID: 11490013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2.
    Yoshimura A; Lien E; Ingalls RR; Tuomanen E; Dziarski R; Golenbock D
    J Immunol; 1999 Jul; 163(1):1-5. PubMed ID: 10384090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endotoxin-induced chemokine expression in murine peritoneal mesothelial cells: the role of toll-like receptor 4.
    Kato S; Yuzawa Y; Tsuboi N; Maruyama S; Morita Y; Matsuguchi T; Matsuo S
    J Am Soc Nephrol; 2004 May; 15(5):1289-99. PubMed ID: 15100369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling.
    Yang RB; Mark MR; Gray A; Huang A; Xie MH; Zhang M; Goddard A; Wood WI; Gurney AL; Godowski PJ
    Nature; 1998 Sep; 395(6699):284-8. PubMed ID: 9751057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide.
    Lien E; Means TK; Heine H; Yoshimura A; Kusumoto S; Fukase K; Fenton MJ; Oikawa M; Qureshi N; Monks B; Finberg RW; Ingalls RR; Golenbock DT
    J Clin Invest; 2000 Feb; 105(4):497-504. PubMed ID: 10683379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.